Metabolic syndrome. Metabolic disorder, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Endurance training: Twelve weeks will be set as intervals. Four days a week, each session includes 10-15 minutes of warming up and cooling down, the first session i
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Male
Age
22 Years to 32 Years
Inclusion criteria
Inclusion criteria: Smokers with a history of at least 3 years Suffering from metabolic syndrome has not participated in any regular sports program for at least the last 3 months Waist circumference greater than or equal to 102 cm Triglyceride level greater than or equal to 150 mg/dL HDL less than 40 mg/dL, blood pressure 130/85 mmHg Fasting blood glucose greater than or equal to 110 mg/dL
Exclusion criteria
Exclusion criteria: Absence of kidney, heart, and nervous diseases No history of surgery Not using hormonal and steroid chemical drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: Measuring the concentration level of lipid profiles at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: 8 cc of blood will be taken from the subjects from the forearm vein. Measurement of the concentration level of lipid profiles by enzyme method (by Pars Azmoun company). | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability. Timepoint: Measurement of resting heart rate at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: Holter monitoring device model VX3 of American DMS company along with Full Option software.;Measurement of interleukin 6-8-10. Timepoint: Measuring the level of immunoglobulin A at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: Immunoglobulin A by ELISA method and using high sensitivity kits (0.11 pg) made in Italy.;Tumor necrosis factor-alpha. Timepoint: Measurement of tumor necrosis factor-alpha at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: Using the ELISA kit made by Buster America.;Measurement of cTnI and cTnT. Timepoint: Measurement of cTnI and cTnT at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: Done by using LIAISON device and advanced Chemiluminescence method.;CK-MB measurement. Timepoint: CK-MB measurement at the beginning of the study (before the start of the intervention) and at the end after 12 weeks of the intervention. Method of measurement: Using the Horiba kit in the colorimetry method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Farzaneh Hesari
Islamic Azad University
Outcome results
None listed